Suppr超能文献

p53序列特异性DNA结合的一个额外负调控区域的鉴定。

Identification of an additional negative regulatory region for p53 sequence-specific DNA binding.

作者信息

Müller-Tiemann B F, Halazonetis T D, Elting J J

机构信息

Institute for Bone and Joint Disorders and Cancer, Bayer Corporation, Pharmaceutical Division, 400 Morgan Lane, West Haven, CT 06516, USA.

出版信息

Proc Natl Acad Sci U S A. 1998 May 26;95(11):6079-84. doi: 10.1073/pnas.95.11.6079.

Abstract

The DNA binding activity of p53 is crucial for its tumor suppressor function and is subject to tight regulation. Previous studies revealed that the inhibitory function of the p53 C terminus is implicated in the latent, low affinity sequence-specific DNA binding activity of p53 in the uninduced state. Sequence-specific DNA binding of p53 has been shown to be activated by several posttranslational modifications and interacting proteins that target predominantly the C terminus. Moreover, several authors have shown that synthetic peptides corresponding to p53 C-terminal sequences activate p53 sequence-specific DNA binding. In an effort to identify the interaction site of p53 with these activating peptides we assessed complex formation between p53 deletion constructs and C-terminal activating peptides by peptide affinity precipitation. This study revealed that two distal regions of the p53 molecule contribute synergistically to the interaction with activating C-terminal peptides: amino acids 80-93 and 364-393. The C-terminal residues 364-393 are already well characterized as having negative regulatory function. DNA binding analyses with these deletion constructs reveal a comparable negative regulatory activity for residues 80-93, defining this region as a previously unidentified negative regulatory domain of p53. Furthermore, synthetic peptides spanning this newly identified proline-rich negative regulatory region (residues 80-93) are able to activate p53 sequence-specific DNA binding in vitro. We suggest that both negative regulatory regions, residues 80-93 and 364-393, contribute cooperatively to the maintenance of the latent, low-affinity DNA binding conformation of p53.

摘要

p53的DNA结合活性对其肿瘤抑制功能至关重要,且受到严格调控。先前的研究表明,p53 C末端的抑制功能与p53在未诱导状态下潜在的、低亲和力序列特异性DNA结合活性有关。p53的序列特异性DNA结合已被证明可被几种主要靶向C末端的翻译后修饰和相互作用蛋白激活。此外,几位作者表明,与p53 C末端序列对应的合成肽可激活p53序列特异性DNA结合。为了确定p53与这些激活肽的相互作用位点,我们通过肽亲和沉淀评估了p53缺失构建体与C末端激活肽之间的复合物形成。这项研究表明,p53分子的两个远端区域协同作用于与C末端激活肽的相互作用:氨基酸80 - 93和364 - 393。C末端残基364 - 393已被充分表征为具有负调控功能。对这些缺失构建体的DNA结合分析揭示了残基80 - 93具有类似的负调控活性,将该区域定义为p53一个先前未被识别的负调控结构域。此外,跨越这个新鉴定的富含脯氨酸的负调控区域(残基80 - 93)的合成肽能够在体外激活p53序列特异性DNA结合。我们认为,负调控区域残基80 - 93和364 - 393共同作用,维持p53潜在的、低亲和力DNA结合构象。

相似文献

1
Identification of an additional negative regulatory region for p53 sequence-specific DNA binding.
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6079-84. doi: 10.1073/pnas.95.11.6079.
4
p53 Latency. C-terminal domain prevents binding of p53 core to target but not to nonspecific DNA sequences.
J Biol Chem. 2001 May 11;276(19):15650-8. doi: 10.1074/jbc.M100482200. Epub 2001 Feb 23.
5
The single-stranded DNA end binding site of p53 coincides with the C-terminal regulatory region.
Nucleic Acids Res. 1996 Sep 15;24(18):3560-7. doi: 10.1093/nar/24.18.3560.
6
Small peptides activate the latent sequence-specific DNA binding function of p53.
Cell. 1995 Oct 20;83(2):237-45. doi: 10.1016/0092-8674(95)90165-5.
7
Regulation of DNA binding of p53 by its C-terminal domain.
J Mol Biol. 2004 Sep 17;342(3):801-11. doi: 10.1016/j.jmb.2004.07.042.
9
A DNA binding domain is contained in the C-terminus of wild type p53 protein.
Nucleic Acids Res. 1991 Oct 11;19(19):5191-8. doi: 10.1093/nar/19.19.5191.
10
The central region of HDM2 provides a second binding site for p53.
Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1227-32. doi: 10.1073/pnas.0510343103. Epub 2006 Jan 23.

引用本文的文献

1
Interaction between p53 N terminus and core domain regulates specific and nonspecific DNA binding.
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):8859-8868. doi: 10.1073/pnas.1903077116. Epub 2019 Apr 15.
2
Alanine and proline content modulate global sensitivity to discrete perturbations in disordered proteins.
Proteins. 2014 Dec;82(12):3373-84. doi: 10.1002/prot.24692. Epub 2014 Oct 10.
3
Negative regulation-resistant p53 variant enhances oncolytic adenoviral gene therapy.
Hum Gene Ther. 2012 Jun;23(6):609-22. doi: 10.1089/hum.2011.114. Epub 2012 Feb 21.
4
Dancing on DNA: kinetic aspects of search processes on DNA.
Chemphyschem. 2011 Jun 6;12(8):1481-9. doi: 10.1002/cphc.201100112. Epub 2011 May 10.
5
An induced fit mechanism regulates p53 DNA binding kinetics to confer sequence specificity.
EMBO J. 2011 Jun 1;30(11):2167-76. doi: 10.1038/emboj.2011.127. Epub 2011 Apr 26.
6
A single-molecule characterization of p53 search on DNA.
Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):563-8. doi: 10.1073/pnas.1016020107. Epub 2010 Dec 22.
7
USP7/HAUSP promotes the sequence-specific DNA binding activity of p53.
PLoS One. 2010 Sep 27;5(9):e13040. doi: 10.1371/journal.pone.0013040.
9
Multiple conformations of full-length p53 detected with single-molecule fluorescence resonance energy transfer.
Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20758-63. doi: 10.1073/pnas.0909644106. Epub 2009 Nov 20.
10
Three assays show differences in binding of wild-type and mutant p53 to unique gene sequences.
Technol Cancer Res Treat. 2009 Dec;8(6):445-53. doi: 10.1177/153303460900800606.

本文引用的文献

1
ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL.
J Mol Biol. 1965 May;12:88-118. doi: 10.1016/s0022-2836(65)80285-6.
2
Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.
Cell. 1997 Aug 22;90(4):595-606. doi: 10.1016/s0092-8674(00)80521-8.
4
A proline-rich motif in p53 is required for transactivation-independent growth arrest as induced by Gas1.
Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4675-80. doi: 10.1073/pnas.94.9.4675.
5
p53, the cellular gatekeeper for growth and division.
Cell. 1997 Feb 7;88(3):323-31. doi: 10.1016/s0092-8674(00)81871-1.
6
Identification of a novel p53 functional domain that is necessary for efficient growth suppression.
Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15335-40. doi: 10.1073/pnas.93.26.15335.
8
V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors.
Genes Dev. 1996 Aug 15;10(16):2038-54. doi: 10.1101/gad.10.16.2038.
10
p53: puzzle and paradigm.
Genes Dev. 1996 May 1;10(9):1054-72. doi: 10.1101/gad.10.9.1054.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验